Cerevel Therapeutics starts public offering of $400M of shares (NASDAQ:CERE)
Summary
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected